DRL receives US FDA’s approval for XEGLYZETM (abametapir) lotion
XEGLYZE is indicated for the topical treatment of head lice infestation in patients 6 months of age and older
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.